4//SEC Filing
Carlson Richard Craig 4
Accession 0001179110-09-004123
CIK 0001222244other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 12:24 PM ET
Size
11.8 KB
Accession
0001179110-09-004123
Insider Transaction Report
Form 4
Carlson Richard Craig
DirectorCEO
Transactions
- Disposition to Issuer
Stock Options
2009-03-03−5,000→ 0 totalExercise: $7.50Exp: 2011-03-02→ Common Stock, $0.00001 par value (5,000 underlying) - Award
Stock Options
2009-03-03+100,000→ 100,000 totalExercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (100,000 underlying)
Holdings
- 10,000
Stock Options
Exercise: $5.00Exp: 2014-02-01→ Common Stock, $0.00001 par value (10,000 underlying) - 850
Common Stock, $0.00001 par value
- 70,000
Stock options
Exercise: $1.00Exp: 2015-07-11→ Common stock, $0.00001 par value (70,000 underlying)
Footnotes (5)
- [F1]The Options shall vest on the date the Commpany is cleared by the FDA to sell the ProUroScan system in the United States.
- [F2]The Option shall vest as enumerated: (a) 10,000 shares are vested and currently exercisable; (b) 20,000 shares vest on each of July 1, 2009, July 1, 2010 and July 1, 2011.
- [F3]The 10,000 options are vested and exercisable. The number of options outstanding was reduced to reflect the expiration of 5,000 performance-based options under the terms of the original option grant.
- [F4]The reporting person and the Company agreed to cancel 5,000 existing, unvested options with an exercise price of $7.50 per share. The Company then issued 100,000 new options to the reporting person with an exercise price of $0.85 per share.
- [F5]The options vest as to 90,000 shares immediately and as to 10,000 shares on January 2, 2010.
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001353829
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 12:24 PM ET
- Size
- 11.8 KB